Dr. Jung is a Distinguished Professor of Chemistry and Biochemistry at the University of California, Los Angeles. He received a B.A. from Rice University in Houston, Texas and a Ph.D. from Columbia University in New York City where he did research with Gilbert Stork. He then obtained a NATO Postdoctoral Fellowship to work with Albert Eschenmoser at the Eidgenössische Technische Hochschule in Zürich, Switzerland. In 1974 he joined the faculty at UCLA, where he has spent his entire career. Dr. Jung's research is focused on the development of new reactions for organic synthesis, including chemical syntheses for a variety of natural products with antitumor and antiviral properties. Dr. Jung's research group developed an antagonist of the androgen receptor which is beginning phase 3 clinical trials for the treatment of hormone refractory prostate cancer. Awards won by Michael Jung include the American Chemical Society's Arthur C. Cope Scholar Award, the Glenn T. Seaborg Award, and the Gold Shield Faculty Prize.